Parametric Portfolio Associates LLC increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 18.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,103,078 shares of the financial services provider’s stock after purchasing an additional 172,937 shares during the period. Parametric Portfolio Associates LLC owned 0.33% of CME Group worth $149,666,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of CME. AXA boosted its holdings in shares of CME Group by 7.2% during the third quarter. AXA now owns 259,774 shares of the financial services provider’s stock worth $35,246,000 after acquiring an additional 17,474 shares during the period. Steward Partners Investment Advisory LLC bought a new stake in shares of CME Group during the third quarter worth approximately $1,276,000. Public Employees Retirement System of Ohio boosted its holdings in shares of CME Group by 85.8% during the third quarter. Public Employees Retirement System of Ohio now owns 434,998 shares of the financial services provider’s stock worth $59,021,000 after acquiring an additional 200,825 shares during the period. Smith Shellnut Wilson LLC ADV bought a new stake in shares of CME Group during the third quarter worth approximately $231,000. Finally, Cypress Capital Group boosted its holdings in shares of CME Group by 1.0% during the third quarter. Cypress Capital Group now owns 64,107 shares of the financial services provider’s stock worth $8,698,000 after acquiring an additional 645 shares during the period. Institutional investors and hedge funds own 83.17% of the company’s stock.
Shares of CME Group Inc (NASDAQ CME) opened at $150.42 on Friday. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. The stock has a market capitalization of $51,413.22, a P/E ratio of 31.72, a P/E/G ratio of 3.11 and a beta of 0.73. CME Group Inc has a 12 month low of $113.27 and a 12 month high of $155.29.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.05 earnings per share. research analysts predict that CME Group Inc will post 4.78 EPS for the current year.
The business also recently declared a None dividend, which will be paid on Monday, January 15th. Investors of record on Thursday, December 28th will be paid a $3.50 dividend. The ex-dividend date is Wednesday, December 27th. CME Group’s dividend payout ratio (DPR) is currently 59.86%.
CME has been the subject of a number of research analyst reports. Barclays initiated coverage on CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 price objective for the company. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, September 1st. UBS restated a “buy” rating and set a $135.00 price objective (up previously from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Citigroup boosted their price objective on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Wells Fargo & Company boosted their price objective on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $141.75.
In related news, insider Hilda Harris Piell sold 1,350 shares of the business’s stock in a transaction that occurred on Thursday, October 5th. The stock was sold at an average price of $138.00, for a total value of $186,300.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey M. Bernacchi sold 1,501 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $149.75, for a total value of $224,774.75. Following the completion of the sale, the director now owns 60,194 shares of the company’s stock, valued at $9,014,051.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 36,628 shares of company stock valued at $5,288,800. 0.57% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This article was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.thelincolnianonline.com/2017/12/15/cme-group-inc-cme-shares-bought-by-parametric-portfolio-associates-llc.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.